Workshop Introduction
The urgent mission of the Foundation Fighting Blindness is to drive the research that leads to preventions, treatments, and cures for degenerative retinal diseases, including those caused by mutations in the PRPH2 gene. Mutations in PRPH2 lead to a variety of dominantly inherited retinal dystrophies, including retinitis pigmentosa, cone-rod dystrophy, pattern dystrophy, and others.
The Foundation Fighting Blindness, together with the Nixon Visions Foundation, invites you to join a free, in-person workshop bringing together individuals and families affected by PRPH2 and associated retinal diseases, along with researchers, physicians, and industry partners. This workshop builds on the highly successful PRPH2 and Associated Retinal Diseases Workshop held in 2023.
Workshop Goals
The main goal of the workshop is to continue to bring awareness and build community across PRPH2-related retinal disease and accelerate research on biological and therapeutic approaches. The workshop will:
- Assess the current state of PRPH2-related retinal diseases.
- Highlight and honor recent scientific advances.
- Identify critical gaps to shape future research and funding priorities.
- Convene patient and scientific communities.
What to Expect
This Workshop is designed to bring together affected individuals and their families, in addition to leading experts from academia, to discuss openly, and in detail, what is known about PRPH2 disease pathology, disease models, clinical characteristics, and therapeutic approaches. Importantly, there will also be opportunities to hear from affected individuals and their families to ensure their perspectives for care, treatment, and therapies inform both research and clinical studies.
Workshop Schedule
The workshop will be held on September 9–11, 2026, at the Hilton La Jolla Torrey Pines in San Diego, CA.
Wednesday, September 9, 2026
|
Start Time |
End Time |
Event |
Presenter/Panelists |
Session Description |
|
5:30 p.m. |
Welcome Reception |
|||
|
6:30 p.m. |
Welcome Remarks |
Brandon Nixon |
Thursday, September 10, 2026
|
Start Time |
End Time |
Event |
Presenter/Panelists |
Session Description |
|
8:30 a.m. |
8:45 a.m. |
Welcome & why are we here? |
Jason Menzo |
Join us for a brief welcome and introduction from the CEO and CSO of the Foundation Fighting Blindness, highlighting the mission, key themes, and goals of the event: |
|
8:45 a.m. |
9:05 a.m. |
Looking back and looking forward: 5 years of supporting PRPH2 research |
Brandon Nixon |
Brandon Nixon, co-founder of Nixon Visions Foundation, will look back over the past five years of supporting PRPH2 research, progress, and hope for the future. |
|
9:05 a.m. |
9:15 a.m. |
Patient Perspective |
Isabelle Ortner |
A patient will share their experiences living with PARD. |
|
9:05 a.m. |
9:25 a.m. |
Setting the Stage: A PRPH2 Primer |
Angela Bowman, PhD Director of Scientific Research Foundation Fighting Blindness |
This session will provide a lay overview of PRPH2 biology, genetics, clinical manifestations, and therapeutic approaches. |
|
9:25 a.m. |
10:20 a.m. |
PRPH2 Foundational Biology |
Moderator: James Birtley, PhD Speakers: 1. Yoshikazu Imanishi, PhD 2. William Spencer, PhD |
This session will cover topics in foundational PRPH2 biology, including models, the cellular function of PRPH2 and how PRPH2 is trafficked to outer segments. |
|
10:20 a.m. |
10:35 a.m. |
Morning Break / Networking |
||
|
10:45 a.m. |
12:00 p.m. |
Genetics and Patient Heterogeneity |
Moderator: Ajoy Vincent, MBBS |
This session will discuss current understanding of PARD phenotypes, challenges associated with patient heterogeneity and studies to uncover how specific variants affect PRPH2 function. |
|
12:05 p.m. |
1:00 p.m. |
Lunch |
||
|
1:00 p.m. |
1:55 p.m. |
Therapeutic Approaches – Genetic Technologies I |
Moderator: Peter Quinn, PhD Panelists: 1. Andrew Goldberg, PhD 2. Krzysztof Palczewski, PhD |
This session will discuss emerging therapeutic approaches for PARD, including gene augmentation, genome editing, and knock down and replace. |
|
1:55 p.m. |
2:05 p.m. |
Patient Perspective |
Angus Patrick |
A patient will share their experiences living with PARD. |
|
2:05 p.m. |
2:30 p.m. |
Break / Networking |
||
|
2:30 p.m. |
3:25 p.m. |
Therapeutic Approaches – Genetic Technologies II |
Moderator: Frauke Coppieters, PhD Speakers: 1. Renee Ryals, PhD 2. Shyamanga Borooah, PhD, MBBS |
This session will cover additional genetic technologies, including delivery modalities and ASOs. |
|
3:25 p.m. |
3:40 p.m. |
Day 1 Wrap Up |
Robert Hufnagel, MD, PhD |
Rob will provide a (lay) summary of day 1. |
|
4:00 p.m. |
5:00 p.m. |
Scientific Gap Round Table Discussion |
Moderator: Angela Bowman, PhD |
This session will engage scientists and clinicians in deep, moderated discussions of gaps associated with key research areas. |
|
4:00 p.m. |
5:00 p.m. |
Patient and Family Gathering |
Moderators: Brandon and Janine Nixon |
|
|
5:30 p.m. |
7:00 p.m. |
Reception |
||
|
7:00 p.m. |
8:30 p.m. |
Dinner |
Speaker: John Samuel |
|
Friday, September 11, 2026
|
Start Time |
End Time |
Event |
Presenter/Panelists |
Session Description |
|
8:45 a.m. |
8:55 a.m. |
Welcome |
Jason Menzo |
Mr. Menzo will welcome attendees to day 2 and cover any housekeeping items. |
|
8:55 a.m. |
9:10 a.m. |
PRPH2 Survey Results |
Naomi Wagner, MS, CGC |
Ms. Wagner will share the results of the PRPH2 patient survey. |
|
9:10 a.m. |
9:40 a.m. |
Therapeutic Approaches - Cell Therapies and Gene Agnostic Approaches |
Moderator: Katie Cording, PhD Shyamanga Borooah, PhD, MBBS |
This session will cover additional therapeutic approaches, including neuroprotection, stem cells, and optogenetics. |
|
9:40 a.m. |
9:50 a.m. |
Patient Perspective |
Estibaliz Simon |
A patient will share their experiences living with PARD. Include a thank you to scientists and researchers. |
|
9:50 a.m. |
10:10 a.m. |
Break |
||
|
10:10 a.m. |
10:50 a.m. |
Round Table Report-Out |
Moderator: Angela Bowman, PhD |
This session will provide an opportunity for a report-out on key takeaways from the scientific round table discussion groups. |
|
10:50 a.m. |
11:00 a.m. |
Patient Perspective |
Virginia Harper Breen |
A patient will share their experiences living with PARD. |
|
11:00 a.m. |
11:30 a.m. |
New and Next |
Moderator: Preeti Subramanian, PhD 1. Qin Liu, MD, PhD 2. Breandán Kennedy, PhD |
The newest PARD awardees will give an overview of their exciting new projects. |
|
11:30 a.m. |
11:45 a.m. |
Summary and Next Steps |
Amy Laster, PhD |
Dr. Laster will provide a summary of the meeting and discuss next steps for accelerating momentum for PARD research. |
|
11:45 a.m. |
11:55 a.m. |
Final Remarks |
Jason Menzo, Brandon Nixon |
Jason and Brandon will close out the workshop |
|
12:00 p.m. |
12:15 p.m. |
Group Photo |
|
|
|
12:15 p.m. |
1:15 p.m. |
Lunch |
||
|
1:00 p.m. |
3:00 p.m. |
Optional tours of Shiley Eye Institute |
||
Questions about the workshop should be addressed to Michele DiVincenzo, Vice President, Scientific and Educational Events, Foundation Fighting Blindness, MDiVincenzo@FightingBlindness.org
The workshop is free to attend, and all meals are included.
How to Attend
To participate in this workshop, you must complete both steps below:
- Registration is currently closed, if you would like to be added to the waitlist, please email Michele DiVincenzo at MDiVincenzo@FightingBlindness.org.
- Book your hotel room separately using the instructions in the Accommodations section.
Accommodations
The Foundation Fighting Blindness has secured a rate of $279/night + daily resort fee of $26.00 for a standard room at the Hilton La Jolla Torrey Pines. Please make your reservations by Tuesday, August 18, 2026, to receive this room rate and ensure availability. All reservations should be made, modified, or canceled by you, the attendee, by completing your reservation online or calling Hilton La Jolla Torrey Pines Reservations at 877-414-8020 and referring to the group reservation code ‘FFB26’.
Landscape Analysis
Scientific Presenters
- Radha Ayyagari, PhD
- Shyamanga Borooah
- Frauke Coppieters, PhD
- Jason Comander, MD, PhD
- Andrew Goldberg, PhD
- Rob Hufnagel, MD, PhD
- Yoshi Imanishi, PhD
- Breandán Kennedy, PhD
- Bart Leroy MD, PhD
- Qin Liu, PhD
- Krzysztof Palczewski, PhD
- Peter Quinn, PhD
- Renee Ryals, PhD
- William Spencer, PhD
- Ajoy Vincent, MBBS
Foundation Fighting Blindness Participants
- Jason Menzo, Chief Executive Officer
- Amy Laster, PhD, Chief Scientific Officer
- Todd Durham, PhD, Senior Vice President, Clinical and Outcomes Research
- Preeti Subramanian, PhD, Vice President, Preclinical Science
- Angela Bowman, PhD, Director, Scientific Research
- Katie Cording, PhD, Science Research Lead